Grant: Discovery Grants Program - Individual
University of Toronto
$31,000.00
Devices to Enable New MRI-Guided Procedures
EF 2019-20
Résumé
With excellent soft tissue contrast, multiplanar capability and lack of ionizing radiation, MRI is already used extensively for planning and performing minimally invasive medical procedures. However, there remains much untapped potential to further integrate MRI into the procedure workflow, with new types of image contrast to provide information to better target treatment, development of new devices so that MR imaging can be used to accurately place devices within complex anatomical structures, and novel treatment paradigms in which treatment is performed during realtime MR imaging to guide delivery. In this research program, novel MRIrelated device technologies are developed and tested so that medical treatments can be better delivered using MRI guidance.****Minimally invasive procedures performed under MRI guidance, such as placement of biopsy needles and brachytherapy applicators, is a promising and evolving field with great clinical potential. One particular challenge of this field, however, has been how to develop safe and reliable methods for making position measurements (i.e. tracking) such devices as they are moved and manipulated to their final location. In the proposed project, this technology will be systematically developed and refined towards commercial applications in realworld medical devices.****Hyperpolarized 13C metabolic MRI is emerging as a promising tool for probing metabolic changes associated with various disease states, notably for its application to cancer. We will develop data acquisition and reconstructions methods tailored to imaging hyperpolarized 13Cpyruvate and 13Clactate. ***Three-dimensional imaging of tumour lactate in cervical cancer patients may be useful in guiding chemo-radiation and brachytherapy. We will develop Radio Frequency coil systems to integrate real-time pelvic molecular imaging into cervical cancer therapy.****This program involves the development of new technologies that together will enable new systems for treatment planning and delivery. Along with the potential for these devices to improve care and survival for Canadians with cancer of the cervix, these technologies all have broad applicability for other MRIguided procedures, and thus have significant commercial potential beyond the applications described in the research program.**
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2016-05566
Name nom
Cunningham, Charles
Department département
Medical Biophysics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:4 - 5
Partie
4
Nb partie
5
Application title
Devices to Enable New MRI-Guided Procedures
Keyword
NSERC
Application summary
With excellent soft tissue contrast, multiplanar capability and lack of ionizing radiation, MRI is already used extensively for planning and performing minimally invasive medical procedures. However, there remains much untapped potential to further integrate MRI into the procedure workflow, with new types of image contrast to provide information to better target treatment, development of new devices so that MR imaging can be used to accurately place devices within complex anatomical structures, and novel treatment paradigms in which treatment is performed during realtime MR imaging to guide delivery. In this research program, novel MRIrelated device technologies are developed and tested so that medical treatments can be better delivered using MRI guidance.****Minimally invasive procedures performed under MRI guidance, such as placement of biopsy needles and brachytherapy applicators, is a promising and evolving field with great clinical potential. One particular challenge of this field, however, has been how to develop safe and reliable methods for making position measurements (i.e. tracking) such devices as they are moved and manipulated to their final location. In the proposed project, this technology will be systematically developed and refined towards commercial applications in realworld medical devices.****Hyperpolarized 13C metabolic MRI is emerging as a promising tool for probing metabolic changes associated with various disease states, notably for its application to cancer. We will develop data acquisition and reconstructions methods tailored to imaging hyperpolarized 13Cpyruvate and 13Clactate. ***Three-dimensional imaging of tumour lactate in cervical cancer patients may be useful in guiding chemo-radiation and brachytherapy. We will develop Radio Frequency coil systems to integrate real-time pelvic molecular imaging into cervical cancer therapy.****This program involves the development of new technologies that together will enable new systems for treatment planning and delivery. Along with the potential for these devices to improve care and survival for Canadians with cancer of the cervix, these technologies all have broad applicability for other MRIguided procedures, and thus have significant commercial potential beyond the applications described in the research program.**